FDA Approves Drug for Phenylketonuria, a Rare Metabolic Disorder

The U.S. Food and Drug Administration (FDA) approved the injectable agent pegvaliase-pqpz for adults with phenylketonuria (PKU), a rare and serious genetic metabolic disease....

FDA Approves Drug for Phenylketonuria, a Rare Metabolic Disorder

The U.S. Food and Drug Administration (FDA) approved the injectable agent pegvaliase-pqpz for adults with phenylketonuria (PKU), a rare and serious genetic metabolic disease. Patients with PKU are unable to break down phenylalanine (Phe),...

#DocWirePicks

#DocWirePicks

This Week`s Featured Journal: JAMA

Latest JAMA Articles

#TheFeed

Latest from the Journals

Latest News from the Web

This Week`s Featured Journal: JAMA

Latest JAMA Articles

#TheFeed

Latest from the Journals

Latest News from the Web